aminocaproic acid has been researched along with Polycystic Kidney Diseases in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TSALTAS, TT | 1 |
| Rao, KV | 1 |
2 other studies available for aminocaproic acid and Polycystic Kidney Diseases
| Article | Year |
|---|---|
LABORATORY EVIDENCE OF SPONTANEOUS EVACUATION OF THE CONTENTS OF CYSTS IN POLYCYSTIC KIDNEYS.
Topics: Aminocaproates; Aminocaproic Acid; Chromium Isotopes; Cysts; Erythrocytes; Hematuria; Humans; Kidney | 1964 |
Use of epsilon aminocaproic acid in protracted bleeding from polycystic kidneys: a case report.
Topics: Adult; Aminocaproates; Aminocaproic Acid; Hematuria; Humans; Male; Polycystic Kidney Diseases; Time | 1986 |